Status:
COMPLETED
Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Antimuscarinic Drug
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Overactive bladder syndrome (OAB) affects around 17 % of female population. However, the etiology of OAB was complicated and unclear in many aspects. In particular, the research about psychiatric aspe...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- all cases are female patients with lower urinary tract symptoms
Exclusion
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT01503580
Start Date
August 1 2008
End Date
October 1 2013
Last Update
October 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gynecology,National Taiwan University Hospital
Taipei, Taiwan